Related Experiment Video
Updated: Jul 30, 2025

Identifying Amino Acid Overproducers Using Rare-Codon-Rich Markers
Published on: June 24, 2019
Overcoming Multidrug Resistance by Base-Editing-Induced Codon Mutation
He-Hua Zhang1, Jian Xiang1, Bin-Cheng Yin1,2
1Lab of Biosystem and Microanalysis, State Key Laboratory of Bioreactor Engineering, Shanghai Collaborative Innovation Center for Biomanufacturing Technology, East China University of Science and Technology, Shanghai 200237, China.
Abstract:
Multidrug resistance (MDR) is the main obstacle in cancer chemotherapy. ATP binding cassette (ABC) transporters on the MDR cell membrane can transport a wide range of antitumor drugs out of cells, which is one of the main causes of MDR. Therefore, disturbing ABC transporters becomes the key to reversing MDR. In this study, we implement a cytosine base editor (CBE) system to knock out the gene encoding ABC transporters by base editing. When the CBE system works in MDR cells, the MDR cells are manipulated, and the genes encoding ABC transporters can be inactivated by precisely changing single in-frame nucleotides to induce stop (iSTOP) codons. In this way, the expression of ABC efflux transporters is reduced and intracellular drug retention is significantly increased in MDR cells. Ultimately, the drug shows considerable cytotoxicity to the MDR cancer cells. Moreover, the substantial downregulation of P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) implies the successful application of the CBE system in the knockout of different ABC efflux transporters. The recovery of chemosensitivity of MDR cancer cells to the chemotherapeutic drugs revealed that the system has a satisfactory universality and applicability. We believe that the CBE system will provide valuable clues for the use of CRISPR technology to defeat the MDR of cancer cells.
Insights
This study uses a cytosine base editor (CBE) to inactivate genes for ATP binding cassette (ABC) transporters, overcoming multidrug resistance (MDR) in cancer chemotherapy. This approach restores drug sensitivity in resistant cancer cells.
Area of Science:
- Molecular Biology
- Cancer Research
- Biotechnology
Background:
- Multidrug resistance (MDR) is a major challenge in cancer chemotherapy.
- ATP binding cassette (ABC) transporters mediate drug efflux, causing MDR.
- Targeting ABC transporters is crucial for overcoming MDR.
Purpose of the Study:
- To implement a cytosine base editor (CBE) system for gene knockout of ABC transporters.
- To reverse MDR in cancer cells by inactivating ABC transporter genes.
- To evaluate the universality and applicability of the CBE system in restoring chemosensitivity.
Main Methods:
- Utilized a cytosine base editor (CBE) system for precise nucleotide editing.
- Induced stop codons (iSTOP) in ABC transporter genes to achieve knockout.
- Assessed the downregulation of P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP).
Main Results:
- Successfully inactivated genes encoding ABC efflux transporters in MDR cells.
- Significantly increased intracellular drug retention and cytotoxicity in MDR cancer cells.
- Demonstrated substantial downregulation of P-gp and BCRP expression.
Conclusions:
- The CBE system effectively knocks out ABC transporter genes, reversing MDR in cancer cells.
- The system shows broad applicability and universality in restoring chemosensitivity.
- CRISPR-based gene editing offers a promising strategy to combat cancer MDR.
More Related Videos
Related Concept Videos
Genome Copying Errors
Treatment Resistant Cancers
Base Excision Repair
The first step of...
Long-patch Base Excision Repair
RNA Editing
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

